Clinical Trials Logo

Wound Infection clinical trials

View clinical trials related to Wound Infection.

Filter by:

NCT ID: NCT00550290 Completed - Wound Infection Clinical Trials

Prophylactic Antibiotics for Prevention of Wound Complications Following Vulvectomy

Start date: October 2007
Phase: Phase 4
Study type: Interventional

This randomized prospective study will specifically investigate the efficacy of a 24 hour post-operative course of broad-spectrum prophylactic antibiotics - namely Cefazolin - in preventing wound infection and wound breakdown following vulvectomy.

NCT ID: NCT00530400 Completed - Clinical trials for Surgical Wound Infection

Study of the Efficacy of Preoperative Cefuroxime Prophylaxis to Prevent Surgical Site Infection in Herniated Disk Surgery

Start date: April 1994
Phase: Phase 4
Study type: Interventional

The purpose of the study is to determine whether a single, pre-operative dose of cefuroxime is effective in preventing surgical site infection in patients undergoing surgery for herniated disk

NCT ID: NCT00508053 Completed - Wound Infection Clinical Trials

When Closing Midline Incisions, do Small Stitches Reduce the Risk for Incisional Hernia, Wound Infection or Dehiscence?

Start date: January 2001
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a technique using very small stitches when closing a midline incision can reduce the risk for wound complications such as incisional hernia, infection or dehiscence.

NCT ID: NCT00484055 Completed - Clinical trials for Postoperative Wound Infection

Local Collagen-Gentamicin and Extra Fixation of the Sternum for Prevention of Sternal Wound Infection in Cardiac Surgery

LOGIX
Start date: January 2007
Phase: N/A
Study type: Interventional

The aim of the present study is to evaluate a new technique for prevention of sternal wound infection consisting of local application of collagen-gentamicin in addition to routine i.v. antibiotic prophylaxis. The technique has been evaluated in a previous randomised study. The aim of the present study is to evaluate the technique after it has been introduced in clinical practise to monitor the bacterial antibiotic susceptibility and to verify that the suggested reduction in sternal wound infection still exits.

NCT ID: NCT00402727 Completed - Diabetic Foot Clinical Trials

Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection

Start date: September 2006
Phase: Phase 3
Study type: Interventional

Patients, who are considered suitable by their physicians to take part in this research, will have a physical examination (including an Electrocardiogram (ECG)), blood and urine samples taken, as well as a sample of the secretions or tissue around their infection site. In addition, the site of the infection will be photographed. The patients will be randomly assigned one of the treatments: intravenous (IV)/per oral (PO) moxifloxacin (drug under evaluation) or IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid (i.e., one of the reference treatments for this kind of infection). The maximum treatment duration will be 21 days, and the minimum will be 7 days. During the hospitalization, the patients will have a physical examination every day. On Day 3-5 during therapy as well as at the end of treatment, the patients will have repeated examinations. These tests and evaluations will be repeated 14 to 28 days after the end of treatment. During this visit, blood and urine samples will be taken only if judged necessary by the physicians.

NCT ID: NCT00375414 Completed - Clinical trials for Head and Neck Neoplasms

Role of Prophylactic Antibiotics in New Introducer PEG-Gastropexy

Start date: October 2003
Phase: N/A
Study type: Interventional

Peristomal infections are the commonest complications of PEG despite prophylactic antibiotics which may result in emergence of resistant micro-organisms like Methicillin resistant Staphylococcus aureus (MRSA). Introducer PEG technique avoids the sojourn of PEG catheter through the oropharynx so chances of infectious complications are negligible. It was not popular because of associated risks and complications. However the new introducer PEG gastropexy has been recently proved to be safe. To determine the incidence of peristomal wound infections during the immediate 7 day post procedure follow up period after the new introducer PEG gastropexy

NCT ID: NCT00353613 Completed - Clinical trials for Surgical Wound Infection

Prevention of Surgical Site Infections

Start date: March 2007
Phase: N/A
Study type: Interventional

The primary research question is whether interventions to prevent caregiver and system errors will increase the proportion of laparotomy patients who receive recommended measures to prevent surgical site infections.

NCT ID: NCT00330278 Completed - Wound Infection Clinical Trials

Timing of Prophylactic Antibiotics for Cesarean Sections

Start date: January 2003
Phase: N/A
Study type: Interventional

This is a randomized, double-blinded placebo controlled trial of cefazolin timing before cesarean section fo infection prophylaxis. Subjects are randomized to cefazolin either 30 minutes prior to skin incision or at time of cord-clamping. Primary outcome is infectious morbidity including wound infections and endometritis.

NCT ID: NCT00323453 Completed - Appendicitis Clinical Trials

Wound Infection Alexis Wound Retractor

Start date: March 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether the incidence of surgical site wound infection will be reduced in open appendectomy patients through the use of the Alexis® wound retractor.

NCT ID: NCT00290290 Completed - Clinical trials for Postoperative Wound Infection

Efficacy Study of Antiseptic Preoperative Scrubs in Prevention of Postoperative Infections

Start date: September 2003
Phase: Phase 3
Study type: Interventional

Most cases of infection of clean-contaminated wounds (wounds without gross spillage of organisms from the gastrointestinal tract) are thought to originate from the skin. Therefore, it is conceivable that application of an optimal antiseptic agent can reduce the rate of surgical wound infections. This trial is to compare the impact of disinfecting the skin with Chloraprep (2%chlorhexidine and 70% isopropyl alcohol) vs. Betadine on the rates of infection of clean-contaminated surgical wounds. The study will also assess the occurrence of adverse effects on the skin from either antiseptic agent and the cost-savings associated with the use of Chloraprep vs Betadine.